Apollo Endosurgery (APEN) – Company Press Releases
-
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022
-
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
-
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
-
Apollo Endosurgery to be Acquired by Boston Scientific
-
Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.
-
Apollo Endosurgery to Participate in Upcoming Investor Conferences
-
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
-
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
-
MIMEDX Announces Leadership Transition
-
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami
-
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
-
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
-
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
-
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity
-
Sharon O'Keefe Joins Apollo Endosurgery Board of Directors
-
Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products
-
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
-
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
-
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
-
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
-
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
-
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
-
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
-
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
-
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
-
Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC
-
Apollo Endosurgery to Present at Four Upcoming Investor Conferences
-
Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
-
Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System
-
Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021
-
Apollo Endosurgery Announces Positive MERIT-Trial Outcomes
-
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock
-
Apollo Endosurgery Announces Commencement of Public Offering of Common Stock
-
Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates
-
Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference
-
Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
-
Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021
-
Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer
-
MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints
-
Apollo Endosurgery to Present at June Investor Conferences
-
Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021
-
Apollo Endosurgery to Present at Sidoti Conference May 20
-
Apollo Endosurgery, Inc. Reports 29% Increase in First Quarter Revenue
-
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders
-
Apollo Endosurgery Announces Appointments to Commercial Leadership Team
-
Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021
-
Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System
-
Apollo Endosurgery Announces Inducement Grant
-
Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures
Back to APEN Stock Lookup